Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.

    Tru-D the Robot Makes N95 Masks Safe for Reuse
    N95 masks. https://pixnio.com/science/medical-science/face-masks-or-respirators#

    Tru-D the Robot Makes N95 Masks Safe for Reuse

      COVID-19 has rapidly spread across the globe. With nearly 2.7 million diagnosed cases, the medical field is overworked. As a result, many hospitals and doctors are experiencing a lack…

    Continue Reading Tru-D the Robot Makes N95 Masks Safe for Reuse
    Check Out This Free Virtual Clinic for People with Atrial Fibrillation
    Jer5150 / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)

    Check Out This Free Virtual Clinic for People with Atrial Fibrillation

    As COVID-19 continues to spread, and the length of our lockdowns increases, many patients with rare diseases and their families are wondering what comes next. How will you receive treatment?…

    Continue Reading Check Out This Free Virtual Clinic for People with Atrial Fibrillation
    The Impact of COVID-19 on Patients with Thalassemia and Sickle Cell Disease: A Webinar Review
    source: pixabay.com

    The Impact of COVID-19 on Patients with Thalassemia and Sickle Cell Disease: A Webinar Review

      As COVID-19 continues to spread across the globe, more and more people are wondering how this virus might affect them. This is especially true for patients with rare diseases,…

    Continue Reading The Impact of COVID-19 on Patients with Thalassemia and Sickle Cell Disease: A Webinar Review
    Exercise Can Reduce Risk of Severe COVID-19 Respiratory Complications, Says UVA Researcher
    source: pixabay.com

    Exercise Can Reduce Risk of Severe COVID-19 Respiratory Complications, Says UVA Researcher

      According to a release from the UVA Health System Newsroom, Dr. Zhen Yan, PhD, discovered that exercise can reduce or totally stop severe respiratory symptoms associated with acute respiratory…

    Continue Reading Exercise Can Reduce Risk of Severe COVID-19 Respiratory Complications, Says UVA Researcher
    CRISPR and COVID-19: The Impact on Biotech
    Sourced from NIH Image Gallery (Public Domain). Credit: Ernesto del Aguila III, National Human Genome Research Institute, NIH

    CRISPR and COVID-19: The Impact on Biotech

      Saying that COVID-19 has impacted the world might just be an understatement. In fact, COVID-19 changed the way we interact with each other, businesses, and the world around us. But how…

    Continue Reading CRISPR and COVID-19: The Impact on Biotech
    Korsuva Given Breakthrough Therapy Indication, Treats Itching from Chronic Kidney Disease
    pixabay.com

    Korsuva Given Breakthrough Therapy Indication, Treats Itching from Chronic Kidney Disease

    According to a news release from Biospace, recent data from the KALM-2 Phase III trial highlighted how Korsuva, an injectable, is beneficial in treating severe itching associated with severe chronic…

    Continue Reading Korsuva Given Breakthrough Therapy Indication, Treats Itching from Chronic Kidney Disease

    La Vacuna Nasal Previene la Pérdida Neuronal en Modelos de Ratones de la Enfermedad de Alzheimer

    Según un artículo en The Asahi Shimbun, científicos japoneses han desarrollado una nueva vacuna para mitigar la degeneración neuronal causada por la enfermedad de Alzheimer. La vacuna, administrada por vía…

    Continue Reading La Vacuna Nasal Previene la Pérdida Neuronal en Modelos de Ratones de la Enfermedad de Alzheimer
    RDMD Gets $14 Million in Financing, Partners with UCB to Research Progressive Supranuclear Palsy
    Source: Pixabay.com

    RDMD Gets $14 Million in Financing, Partners with UCB to Research Progressive Supranuclear Palsy

      According to BioSpace, healthcare technology company RDMD has raised $14 million in Series A financing, and developed a partnership with UCB. In addition to growing their platform to discuss…

    Continue Reading RDMD Gets $14 Million in Financing, Partners with UCB to Research Progressive Supranuclear Palsy